UnknownNot Applicable

Stereotactic Body Radiation Therapy Versus Radiofrequency Ablation for Small Renal Masses

Canada24 participantsStarted 2019-10-01

Plain-language summary

The execution of this study is pertinent to evaluating SBRT's short- and long-term efficacy and safety in the treatment of SRMs. This study will be the first to compare RFA and SBRT in the treatment of SRMs.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients ≥18 years of age and capable of providing informed consent * Patients scheduled for treatment of their SRM using SBRT or RFA * Patients who received a biopsy of their SRM prior to their scheduled SBRT or RFA treatment * Patients who are willing to have a biopsy 12 months post-procedure * Patients with renal tumor(s) ≤ 4.0 cm Exclusion Criteria: * Patients with large renal tumor(s)\>4.0 cm * Patients who are unable to have a general anesthetic * Patients who did not receive a biopsy of their SRM prior to their scheduled SBRT or RFA treatment * Patients who are unable to comply with post-operative and/or follow-up protocol/phase of study * Evidence of metastatic disease * Uncorrectable bleeding diathesis

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Treatment failure

Timeframe: 12 Months

Overall Survival

Timeframe: 12 Months

Disease free survival

Timeframe: 12 Months

Disease recurrence

Timeframe: 12 Months

Trial details

NCT IDNCT03811665

SponsorSt. Joseph's Healthcare Hamilton

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-30

View on ClinicalTrials.gov More Small Renal Masses (SRM) trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.